The Role of Hydrocortisone for Hypotension in Extremely Low Birth Weight Infants
The Role of Hydrocortisone for Hypotension in Extremely Low Birth Weight Infants is organized by The Pediatrix Center for Research, Education, Quality and Safety (CREQS).
Release Date: 08/06/2021
Expiration Date for Credit: 08/05/2024
Overview
Extremely low birth weight (ELBW) infants are at risk for hypotension. The administration of hydrocortisone (HC) may be an effective treatment for hypotension in some infants. This presentation will address the trends in use of HC, dosing ranges and the associated risks.
ACCME Objectives
• Discuss the rationale for using hydrocortisone for hypotension.
• Summarize the risks associated with the use of high dosage hydrocortisone.
ANCC Learning Outcomes
• Discuss the rationale for using hydrocortisone for hypotension.
• Summarize the risks associated with the use of high dosage hydrocortisone.